Your browser doesn't support javascript.
loading
Uterine serous carcinoma: Molecular features, clinical management, and new and future therapies.
Lee, Elizabeth K; Fader, Amanda N; Santin, Alessandro D; Liu, Joyce F.
Afiliación
  • Lee EK; Division of Gynecologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.
  • Fader AN; Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD, United States of America.
  • Santin AD; Department of Obstetrics, Gynecology & Reproductive Sciences, Yale University School of Medicine, New Haven, CT, United States of America.
  • Liu JF; Division of Gynecologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America. Electronic address: joyce_liu@dfci.harvard.edu.
Gynecol Oncol ; 160(1): 322-332, 2021 01.
Article en En | MEDLINE | ID: mdl-33160694
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Uterinas / Cistadenocarcinoma Seroso Tipo de estudio: Clinical_trials Límite: Female / Humans Idioma: En Revista: Gynecol Oncol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Uterinas / Cistadenocarcinoma Seroso Tipo de estudio: Clinical_trials Límite: Female / Humans Idioma: En Revista: Gynecol Oncol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos